NewsRx

Search our medical news database

Oncology Business Week

Susan Hasty, Publisher

Table of Contents . . . September 4th, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Oncology Business Week | Other Publications

Amgen - U.S. FDA grants panitumumab fast-track status for metastatic colorectal cancer

Amgen Inc. - Palifermin compound receives positive regulatory opinion for approval in Europe

Genitope Corp. - Cancer-focused immunotherapy company reports Q2 net loss of $8.2 million

GlobeImmune, Inc. - Immunotherapy company names Francis V. Chisari, MD, to scientific advisory board

Infrared Sciences Corp. - Maker of breast cancer detection system receives $2.1 million additional funding

Northwest Biotherapeutics, Inc. - Biotechnology company announces appointment of medical director

Schering AG - CONFIRM 2 trial shows low probability of demonstrating improvement

Tapestry Pharmaceuticals, Inc. - Pharmaceutical company focused on cancer treatments reports Q2 2005 results

Technical University of Dresden - Findings describe new data in urology research

Telik Inc. - Safety and efficacy of TLK286 assessed

University of Grenoble, Meylan - Anticancer multidrug resistance mediated by MRP1

Varian Medical Systems, Inc. - Norway cancer clinic integrates hardware and software in radiotherapy department

iCAD, Inc. - Computer-aided detection systems company reports Q2 2005 operating results

Adherex Technologies, Inc. - Two additional sites initiated for phase II trial of ADH-1

Adrenal Cancer - Woman diagnosed with adrenal tumor and congenital adrenal hyperplasia

American Medical Group Association - Physicians see financial losses, despite modest increases in compensation

American University of the Caribbean, St. Maarten - Clinical anatomy of inferior phrenic artery delineated

Aphton Corporation - Oncology company reports loss of $0.21 per share

Baylor Institute for Immunology Research - Cytokine secretion by CD4+T cells reported after dendritic cell vaccine

Bellaria Hospital, Bologna - Gemcitabine plus oxaliplatin used as first-line chemotherapy

Bonn Inst. of Plant Diseases - Corn grain mold used as pesticide

Bristol-Myers Squibb Company - Pharmaceutical company reports earnings of $0.50 per share

CHUA Michallon - Radiotherapy after surgery best option for prostate cancer patients

Calorie Control Council - Study confirms safety of aspartame

Cambridge University Hospital NHS Foundation Trust - Morbidity after sentinel lymph node biopsy in primary breast cancer evaluated

Case Western Reserve University, Cleveland - Mdm2 uses alternate protein to spur tumor growth during hypoxia

Catholic University of Korea, Seoul - Novel oncogene HCCR analyzed

Catholic University of Leuven - Web-based microarray classification benchmarking tool developed

Center Eugene Marquis, Rennes - Time between surgery and radiotherapy affected local recurrence

Center Hospital, Compiegne - Efficacy of tamoxifen in advanced hepatocellular carcinoma evaluated

Center Leon Berard, Lyon - Persistence of medical change at implementation of clinical guidelines assessed

Centro Regional de Oncologia de Lisboa, Lisbon - Fine needle aspiration cytology compared to serum calcitonin measurement

China Medical University Hospital, Taichung - Chemotherapy response in untreated small cell lung cancer evaluated

Christie Hospital NHS Trust, Manchester - Fulvestrant and anastrozole show benefit for improved breast cancer survival

Chung Shan Medical University, Taichung - Ornithine decarboxylase prevented tumor necrosis factor-alpha-induced apoptosis

City of Hope National Medical Center, Duarte - Short hairpin RNA triggers de novo methylation in human cells

Cold Spring Harbor Laboratory - New research in the area of proteomics detailed

Columbia University - Barriers to minority participation in breast cancer prevention trials identified

Dalhousie University - Laparoscopic resection safe and effective

Dharamshila Cancer Hospital, Delhi - Phase II study of gemcitabine, paclitaxel, and cisplatin conducted

Duke University, Durham - Adjuvant external-beam radiotherapy and chemotherapy treated gallbladder cancer

Eastern Hepatobiliary Surgery Institute, Shanghai - Reports describe recent advances in liver cancer research

Emory University, Atlanta - Different outcomes following silica exposure characterized

Environmental Health - Childhood cancers strongly linked to air pollution in early life

Erasmus MC, Rotterdam - QoL self-reported by elderly NHL patients treated with CHOP chemotherapy

Firat University, Elazig - Cutaneous myiasis caused by Wohlfahrtia magnifica

Fourth Military Medical University - Heat shock/MAGE-3 fusion protein vaccine enhances immunity to MAGE-3

Fox Chase Cancer Center, Philadelphia - Complete response to neoadjuvant chemoradiotherapy linked to improved survival

Geisinger Health System - Health organization joins Cancer Alliance Bioinformatics Consortium

German Cancer Research Center, Heidelberg - New data illuminates research in proteomics

Herakleion University, Crete - Studies advance knowledge in breast cancer research

Hokkaido University - Imaging modalities for arteriovenous malformations compared

Hokkaido University - Management of superficial leiomyosarcoma reviewed

Hopital St. Marguerite, Marseille - Usefulness of pancreaticoduodenectomy evaluated

Hospital University of San Carlos, Madrid - Recent studies add new data to breast cancer research

Howard University, Washington - Strategies for conducting research with low-income African American populations

ImClone Systems Inc. - Reports advance knowledge in oncology research

Institute Gustave Roussy, Villejuif - Salvage surgery performed after failure of very accelerated radiotherapy

International Agency for Research on Cancer, Lyon - Risk of cancer after low doses of ionizing radiation evaluated

IsoRay, Inc. - Medical isotope maker completes merger, becomes subsidiary of public company

Jikei University - Dendritic cell vaccine plus IL-12 shows promise against liver cancer

Johns Hopkins University - Protein linked to growth of organs and cancer

Karolinska Institute - Perception and assessment of symptom occurrence and symptom distress compared

Karolinska University Hospital - Mutations in Rb1 pathway-related genes associated with poor prognosis

Keio University - New findings in the area of cancer vaccines detailed

King Faisal Specialist Hospital - Value of nm23 as prognosticator of parathyroid neoplasia assessed

Luxembourg National Health Laboratory - Colon cancer in Luxembourg analyzed

M.D. Anderson Cancer Center - Atiprimod induced apoptosis in multiple myeloma cells

M.D. Anderson Cancer Center - Cytotoxicity of combinatory taxane and platinum treatment evaluated

M.D. Anderson Cancer Center - Somatic symptoms of chronic non-cancer-related and cancer-related pain compared

M.D. Anderson Cancer Center - Symptom distress linked to survival in outpatients

Massachusetts General Hospital - Etoposide continually alternated with topotecan in refractory solid tumors

Massachusetts Institute of Technology, Cambridge - Transformed bronchioalveolar stem cells give rise to adenocarcinoma

Mayo Clinic - Open nephron-sparing surgery remains the "gold standard"

Mayo Clinic - Vitamin and mineral supplementation associated with better outcome in NSCLC

Memorial Sloan-Kettering Cancer Center - Complications occurred in smokers after postmastectomy

Memorial Sloan-Kettering Cancer Center - Craniofacial resection treated malignant paranasal sinus tumors

Memorial Sloan-Kettering Cancer Center - Integrin beta signaling domain effects of deletion defined

Memorial Sloan-Kettering Cancer Center - Researchers identify gene set linked to breast cancer's spread to lungs

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook